Medical Research Archives - Integrity Locums

Where are we with Zika?

Wednesday, November 1st, 2017 in Medical Research.

With science and medical technology advancing at exponential rates it’s no wonder that 2016 brought us many fascinating medical news stories.  One of the biggest health stories of 2016 was the Zika virus but is there a vaccine yet?  Zika Zika, a mosquito-borne African virus was big news throughout 2016.  The virus started to attract more Read more…

Weekly consumption of chocolate linked to lower risk for diabetes and cognitive decline according to new study

Tuesday, January 24th, 2017 in Medical Research.

Chocolate is generally considered to be a popular treat or dessert.  However, people’s love of chocolate might be based on more than just taste.  There may be health-related reasons for the universal popularity of chocolate.  We don’t typically think of our medicine as tasting good, so chocolate as medicine may be a difficult idea to Read more…

Competitively Priced Epi Pens Make it to Market

Thursday, November 10th, 2016 in Healthcare Technology Development, Medical Research.

The requirement for 100% reliability in treating an anaphylactic attack is the primary reason that manufacturers have been reluctant to enter the epi-pen market.  Auvi-Q had previously failed in its bid to compete with the EpiPen. Richmond, Va.-based Kaléo, plans to revamp Auvi-Q after ending its licensing agreement with French company Sanofi in February.  Sanofi recalled Read more…

New Study Indicates Role of Fungi in Crohn’s Disease

Thursday, October 20th, 2016 in Medical Industry News, Medical Research.

Crohn’s disease belongs to a group of conditions known as Inflammatory Bowel Diseases (IBD). Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract.  Crohn’s disease can affect any part of the GI tract. While symptoms vary from patient to patient, the common symptoms of Crohn’s disease include persistent diarrhea, rectal bleeding, urgent need Read more…

Biotech Startup Targets Alzheimer’s, Parkinson’s & ALS

Monday, September 26th, 2016 in Healthcare Technology Development, Medical Research.

Denali Therapeutics, the company formed last year by three former executives of  legendary Genentech to develop Alzheimer’s, Parkinson’s and ALS treatment, is beginning to share their plans for the $217 million raised in venture capital. Announcing that they have raised another $130 million from investors, Marc Tessier-Lavigne, a well-known neuroscientist, president of Rockefeller University in New Read more…

FDA Approval of New Concussion Testing Devices

Wednesday, September 7th, 2016 in Medical Field: Trauma/Emergency, Medical Field: Urgent Care, Medical Research, Specialty Primary Care.

According to the CDC, traumatic brain injuries account for more than 2 million emergency room visits annually in the U.S.  The majority of these injuries are considered non-life threatening, including concussions; although awareness regarding the possibility of complications resulting from a concussion has risen in recent years. Studies have determined that chronic traumatic encephalopathy (CTE), Read more…

Seeking More Effective Clinical Drug Trial Recruitment

Friday, August 19th, 2016 in Medical Research.

  As recently reported on WSJ.com, it is estimated that 1.7 million patients participate in 80,000 drug-company sponsored trials globally each year. Researchers are finding it more difficult to attract and retain the requested number of patients in order to complete studies on time and within budget. There are significant challenges to clinical drug trial Read more…

Pancreatic Transplant Offers Hope for Diabetes Cure

Friday, August 12th, 2016 in Medical Research.

For those living with Type 1 diabetes, their treatment regimen dictates how they live their life. As the patient’s pancreas doesn’t make insulin correctly – and insulin is imperative in blood sugar control – patients must be subjected to multiple daily injections, or wear an insulin pump. Necessary monitoring of glucose levels around every mealtime Read more…